A Canadian investor is prepared to funnel more than $775 million into the U.S. biotech real estate market as part of plan to expand in two of the nation's most prominent life science hubs.
A Canadian investor is prepared to funnel more than $775 million into the U.S. biotech real estate market as part of plan to expand in two of the nation's most prominent life science hubs.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In